Organoheterocyclic compounds (total related compounds in database, current show from 31 to 34) |
|
|
5-[4-(3,4-dihydroisoquinolin-2(1H)-yl)-3-nitrobenzylidene]-2-thioxodihydropyrimidine-4,6(1H,5H)-dione |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Hu X, et al. 2013. Bioorg Med Chem Lett |
|
5-({4-[(2-chloro-6-fluorophenyl)methoxy]phenyl}methylidene)-1,3-dimethyl-1,3-diazinane-2,4,6-trione |
Depiction based on curated SMILES
Cl
O
CH
3
N
O
F
CH
3
O
O
N
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Hu X, et al. 2013. Bioorg Med Chem Lett |
|
7-[[4-(4-fluorophenyl)piperazin-1-yl]methyl]-5-nitroquinolin-8-ol |
Depiction based on curated SMILES
N
OH
F
O
N
N
_
O
+
N
|
Chlamydia Yersinia |
TTSS (Type III secretion system) TTSS (Type III secretion system) |
Preclinical (in vitro) Preclinical (in vitro) |
Enquist PA, et al. 2012. Bioorg Med Chem Lett
|
|
(Z)-{2,2,2-trifluoro-1-[1-(4-fluorophenyl)-5-(4-methanesulfonylphenyl)-2-methyl-1H-pyrrol-3-yl]ethylidene}amino 4-fluorobenzoate |
Depiction based on curated SMILES
O
O
CH
3
N
O
O
S
F
F
F
F
N
H
3
C
F
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Hu X, et al. 2013. Bioorg Med Chem Lett |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.
|
Back to top |
|